PA 2120 (Valproic acid 250 mg)

Pill imprint PA 2120 has been identified as Valproic acid 250 mg.

Valproic acid is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; migraine prevention; mania (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for PA 2120

Valproic acid 250 mg PA 2120
Valproic acid 250 mg PA 2120
Valproic acid
Imprint:
PA 2120
Strength:
250 mg
Color:
White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
50111-0852
Inactive Ingredients:
corn oil
FD&C Blue No. 1
gelatin
glycerin
water
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)